ArticleBiological trace element research2026
Effects of Copper Glycinate Replacing High-Dose Copper Sulfate on Growth Performance, Trace Element Metabolism and Stem Cell Activity in Growing Pigs.
Article in Biological trace element research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Level and Source of Copper Affects Gene Expression of Copper-Regulatory Proteins and Soluble and Mucosal Copper Concentrations in the Small Intestine of Weanling Pigs.Animals : an open access journal from MDPI · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
This study aimed to investigate the effects of different copper sources (copper sulfate and copper glycinate) on growth performance, trace element metabolism and intestinal stem cell activity in growing pigs. In experiment 1, 30 castrated male pigs (Landrace × Large White; initial body weight of 43.11 ± 1.20 kg) were randomly assigned to three treatment groups (n = 10): (1) high-dose CuSO₄ group (150 mg/kg Cu as CuSO₄•5 H₂O), (2) low-dose CuSO₄ group (20 mg/kg Cu as CuSO₄•5 H₂O), (3) Cu-Gly group (20 mg/kg Cu as copper glycinate). The trial lasted for 30 days. The results showed that pigs fed 20 mg/kg Cu as Cu-Gly had final body weight (P = 0.247) and weight gain (P = 0.732) comparable to those fed 150 mg/kg Cu as CuSO₄, while exhibiting a significantly improved feed conversion ratio. Additionally, hepatic iron concentration in the Cu-Gly group was significantly higher than in the high-dose CuSO₄ group, whereas renal copper accumulation was lower. Fecal copper excretion in the Cu-Gly group was reduced by 76.38% compared to the high-dose CuSO₄ group(P < 0.0001). In experiment 2, an in vitro porcine small intestinal organoid culture system was employed. Our results indicated that the lower dose of copper markedly improved intestinal organoid budding and stem cell amplification (P < 0.01), and Cu-Gly significantly improved the intestinal organoid surface area and stem cell differentiation (P < 0.001). Simultaneously, the high dose of copper treatment significantly inhibited the minerals transported related gene expression (DMT1, ZIP4, CTR1, ZIP8), but induced the MT1A and MT3 expression in organoids (P < 0.01). Thus, our study finds a relatively effective way to substitute for pharmacological doses of copper, probably via regulating the minerals metabolism and improving the intestinal stem cell proliferation and differentiation.
Indexed as
Identifiers
41824266What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.